• Note d'application

Furosemide

Furosemide

  • Waters Corporation

This is an Application Brief and does not contain a detailed Experimental section.

Abstract

This application brief demonstrates analysis of furosemide.

Introduction

The compound analyzed in this study is furosemide (USP Tailing Factors - 1.30).

Experimental

HPLC Method

Column:

Symmetry Shield RP18, 4.6 x 150 mm, 5 μm

Part number:

186000109

Mobile phase:

20 mM phosphate buffer, pH 7.0/acetonitrile 75:25

Flow rate:

1.0 mL/min

Injection volume:

5 μL

Detection:

UV @ 220 nm

Results and Discussion

Featured Products

WA31763.88, June 2003

Haut de la page Haut de la page